Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Meliha Nalçacı"'
Autor:
Tahir Darcın, Istemi Serın, Mehmet Can Ugur, Omer Ekinci, İpek Yönal Hindilerden, Seval Akpınar, Tuba Hacıbekiroglu, Sinan Demircioğlu, Emine Gulturk, Murat Albayrak, İsmet Aydoğdu, Mehmet Sinan Dal, Mehmet Hilmi Doğu, Sinem Namdaroğlu, Ali Dogan, Meliha Nalçacı, Burhan Turgut, Semih Başcı, Fevzi Altuntaş
Publikováno v:
Hitit Medical Journal, Vol 6, Iss 2, Pp 186-192 (2024)
Objective: We present data of patients with relapsed/ refractory T cell lymphomas treated with brentuximab vedotin (BV) in real-world practice. Material and Method: This study is an observational, multi-center, retrospective study. The data of patien
Externí odkaz:
https://doaj.org/article/9ca01e30518240fc9f0619b73350c36a
Autor:
Fehmi Hindilerden, Özge Nuran Akay, Elif Aksoy, Aynur Daglar Aday, Emine Gültürk, Meliha Nalçacı, İpek Yönal Hindilerden
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp 2-3 (2024)
Objective: Philadelphia chromosome-negative myeloproliferative neoplasms (Ph- MPNs) are characterized by clonal myeloproliferation and somatic mutations. Major complications of Ph-MPNs are thrombosis, bleeding, transformation to myelofibrosis and leu
Externí odkaz:
https://doaj.org/article/31af40f7c73d4937be3657f709e111a7
Autor:
Simge Erdem, Meliha Nalçacı
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 1, Pp 55-56 (2024)
Externí odkaz:
https://doaj.org/article/1c8abba7fdb845d3ae2d62ffefb33c65
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 3, Pp 174-182 (2023)
Objective: The impact of JAK2V617F allele burden on clinical course in Philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) is not clear. We analyzed the clinical impact of JAK2V617F allele burden in a relatively large series of pa
Externí odkaz:
https://doaj.org/article/b3485c7898604b8e994962da9794d8d5
Autor:
Eren Arslan Davulcu, Tarık Onur Tiryaki, Elif Aksoy, Emine Gültürk, İpek Yönal Hindilerden, Meliha Nalçacı, Fehmi Hindilerden
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S39-S40 (2023)
Objective: Autoimmune hemolytic anemias (AIHA) are rare disorders where autoantibodies destroy self-red blood cells. AIHA includes warm AIHA (wAIHA), cold AIHA (cAIHA or cold agglutinin disease), mixed AIHA (mAIHA), paroxysmal cold hemoglobinuria (PC
Externí odkaz:
https://doaj.org/article/0edee5796bdc4344843d84c23bd75bdf
Autor:
Tarık Onur Tiryaki, Sıdıka Gülkan Özkan, Simge Erdem, Aynur Dağlar Aday, İpek Yönal Hindilerden, Aslı Gelincik, Can Baykal, Gülçin Yegen, İbrahim Öner Doğan, Nesimi Büyükbabani, Meliha Nalçacı, Akif Selim Yavuz
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Mastocytosis is a very rare disorder and is divided into three prognostically distinct variants by World Health Organization: Cutaneous mastocytosis (CM), systemic mastocytosis (SM), and mast cell sarcoma or localized mast cell (MC) tumors.
Externí odkaz:
https://doaj.org/article/b3e0e63abb90432b9167a0783d6e5362
Autor:
Murat Özbalak, Metban Mastanzade, Dilek Özden Özlük, Tarık Onur Tiryaki, Simge Erdem, Ezgi Pınar Özbalak, Tuğrul Elverdi, İpek Yçnal Hindilerden, Ali Yılmaz Altay, Gülçin Yeğen, Ahmet Emre Eşkazan, Muhlis Cem Ar, Mustafa Nuri Yenerel, Teoman Soysal, Meliha Nalçacı, Burhan Ferhanoğlu, Sevgi Kalayoğlu Beşışık
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 4, Pp 254-261 (2022)
Objective: Redditux® (RED), as a biosimilar rituximab, was approved in Turkey for all indications of the original Mabthera® (MAB) in March 2018. The aim of our study was to evaluate the efficacy and safety of RED in de novo diffuse large B-cell lym
Externí odkaz:
https://doaj.org/article/2a9fff72faa5467abb4cb2fad80cdfb5
Autor:
Mustafa Altınkaynak, Pelin Karaca Özer, Adem Atıcı, Rafet Başar, Nida Öztop, Berrin Umman, Meliha Nalçacı
Publikováno v:
İstanbul Medical Journal, Vol 22, Iss 4, Pp 300-305 (2021)
Introduction:Two-dimensional speckle tracking echocardiography (2D-STE) is sensitive in the assessment of left ventricular (LV) systolic function and may aid in diagnosis of late cardiac effects in asymptomatic Hodgkin’s lymphoma (HL) survivors in
Externí odkaz:
https://doaj.org/article/10b417fb8791475dbd523f6f45a43338
Publikováno v:
Case Reports in Hematology, Vol 2020 (2020)
Multiple myeloma is a type of plasma cell disorder and can be seen in different forms. According to current knowledge, it is not a curable disease. Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder and distinguished fro
Externí odkaz:
https://doaj.org/article/f3e67846fe4d4eaa89d51ec64492105a
Autor:
Fehmi Hindilerden, Ipek Yönal Hindilerden, Mustafa Nuri Yenerel, Meliha Nalçacı, Reyhan Diz Küçükkaya
Publikováno v:
Turkish Journal of Hematology, Vol 34, Iss 1, Pp 72-80 (2017)
Objective: This paper prospectively evaluates the long-term followup [mean +- standard deviation (SD) duration: 89.7+-19.4 months] data of 15 patients (13 females and 2 males) with refractory symptomatic immune thrombocytopenia (ITP) treated with rit
Externí odkaz:
https://doaj.org/article/bcce001881d74681bd25f93dbdf58368